RLYB
Income statement / Annual
Last year (2023), Rallybio Corporation's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Rallybio Corporation's net income was -$74.56 M.
See Rallybio Corporation�s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Cost of Revenue |
$150,000.00 |
$167,000.00 |
$109,000.00 |
$62,030.00 |
$26,344.00 |
Gross Profit |
-$150,000.00 |
-$167,000.00 |
-$109,000.00 |
-$62,030.00 |
-$26,344.00 |
Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
Research and Development
Expenses |
$53.54 M
|
$40.69 M
|
$26.91 M
|
$17.63 M
|
$11.37 M
|
General & Administrative
Expenses |
$25.39 M
|
$27.20 M
|
$18.74 M
|
$7.67 M
|
$6.28 M
|
Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General &
Administrative Expenses |
$25.39 M
|
$27.20 M
|
$18.74 M
|
$7.67 M
|
$6.28 M
|
Other Expenses |
$0.00 |
$342,000.00 |
$96,000.00 |
$241,000.00 |
$24,000.00 |
Operating Expenses |
$78.93 M |
$67.88 M |
$45.65 M |
$25.30 M |
$17.64 M |
Cost And Expenses |
$78.93 M |
$67.88 M |
$45.65 M |
$25.30 M |
$17.64 M |
Interest Income |
$6.15 M |
$1.96 M |
$54,000.00 |
$171,000.00 |
$197,000.00 |
Interest Expense |
$0.00 |
$0.00 |
$10,000.00 |
$49,000.00 |
$39,000.00 |
Depreciation &
Amortization |
$150,000.00
|
$167,000.00
|
$109,000.00
|
$62,030.00
|
$26,344.00
|
EBITDA |
-$72.37 M
|
-$65.41 M
|
-$45.39 M
|
-$24.83 M
|
-$17.39 M
|
EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
Total Other
Income/Expenses Net |
$4.37 M
|
$2.31 M
|
$140,000.00
|
$363,000.00
|
$182,000.00
|
Income Before Tax |
-$74.56 M |
-$65.58 M |
-$45.51 M |
-$24.94 M |
-$17.46 M |
Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
Income Tax Expense |
-$2.04 M |
$908,000.00 |
$1.50 M |
-$15,000.00 |
$166,000.00 |
Net Income |
-$74.56 M |
-$66.49 M |
-$47.01 M |
-$24.93 M |
-$17.63 M |
Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
EPS |
-1.84 |
-2.09 |
-1.46 |
-0.78 |
-0.55 |
EPS Diluted |
-1.84 |
-2.09 |
-1.46 |
-0.78 |
-0.55 |
Weighted Average Shares
Out |
$40.45 M
|
$31.82 M
|
$32.13 M
|
$32.13 M
|
$32.13 M
|
Weighted Average Shares
Out Diluted |
$40.45 M
|
$31.82 M
|
$32.13 M
|
$32.13 M
|
$32.13 M
|
Link |
|
|
|
|
|